Zenon Konteatis

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Mingzong Li, Zenon Konteatis, Nelamangala Nagaraja, Yue Chen, Shubao Zhou, Guangning Ma, Stefan Gross, Katya Marjon, Marc L Hyer, Everton Mandley, Max Lein, Anil K Padyana, Lei Jin, Shuilong Tong, Rachel Peters, Joshua Murtie, Jeremy Travins, Matthew Medeiros, Peng Liu, Victoria Frank, Evan T Judd, Scott A Biller, Kevin M Marks, Zhihua Sui, Samuel K Reznik
Leveraging Structure-Based Drug Design to Identify Next-Generation MAT2A Inhibitors, Including Brain-Penetrant and Peripherally Efficacious Leads. Journal of medicinal chemistry 65 (6) (2022)
Zenon Konteatis, Jeremy Travins, Stefan Gross, Katya Marjon, Amelia Barnett, Everton Mandley, Brandon Nicolay, Raj Nagaraja, Yue Chen, Yabo Sun, Zhixiao Liu, Jie Yu, Zhixiong Ye, Fan Jiang, Wentao Wei, Cheng Fang, Yi Gao, Peter Kalev, Marc L Hyer, Byron DeLaBarre, Lei Jin, Anil K Padyana, Lenny Dang, Joshua Murtie, Scott A Biller, Zhihua Sui, Kevin M Marks
Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor for the Treatment of Tumors with Homozygous MTAP Deletion. Journal of medicinal chemistry 64 (8) (2021)

Zenon Konteatis.css-eqlu8i{font-size:small;padding-left:4px;}